Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Chapman

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Geriatric Oncology|May 17, 2017
Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancerGinah Nightingale, Emily Hajjar, Laura T Pizzi, et al.
Journal of Geriatric Oncology|April 20, 2021
The Cancer and Aging Research Group (CARG) infrastructure: The clinical implementation coreAshley E Rosko, Christopher Steer, Leana Cabrera Chien, et al.
Seminars in Radiation Oncology|March 28, 2002
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapyMaria Werner-Wasik, Rita S Axelrod, David P Friedland, et al.
Journal of Geriatric Oncology|March 11, 2019
Treatment plan consistency with guidelines for older adults with cancerAmy R MacKenzie, Andrea M Barsevick, Ronald Myers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
Status of the Clinician Investigator in America: An Essential Healthcare Provider Driving Advances in Cancer CareRandall F Holcombe, Claire F Verschraegen, Andrew E Chapman, et al.
Journal of Geriatric Oncology|February 11, 2015
Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumorsAjeet Gajra, Heidi D Klepin, Tao Feng, et al.
Journal of Geriatric Oncology|December 10, 2019
Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancerReena V Jayani, Allison M Magnuson, Can-Lan Sun, et al.
JCO Oncology Practice|July 21, 2025
Oncology Medical Homes: ASCO-Community Oncology Alliance StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Cancer|May 26, 2018
Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancerEnrique Soto-Perez-de-Celis, Can-Lan Sun, William P Tew, et al.
Cancer|November 14, 2023
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trialJingran Ji, Marie Bae, Can-Lan Sun, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Geriatric Oncology|May 17, 2017
Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancerGinah Nightingale, Emily Hajjar, Laura T Pizzi, et al.
Journal of Geriatric Oncology|April 20, 2021
The Cancer and Aging Research Group (CARG) infrastructure: The clinical implementation coreAshley E Rosko, Christopher Steer, Leana Cabrera Chien, et al.
Seminars in Radiation Oncology|March 28, 2002
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapyMaria Werner-Wasik, Rita S Axelrod, David P Friedland, et al.
Journal of Geriatric Oncology|March 11, 2019
Treatment plan consistency with guidelines for older adults with cancerAmy R MacKenzie, Andrea M Barsevick, Ronald Myers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
Status of the Clinician Investigator in America: An Essential Healthcare Provider Driving Advances in Cancer CareRandall F Holcombe, Claire F Verschraegen, Andrew E Chapman, et al.
Journal of Geriatric Oncology|February 11, 2015
Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumorsAjeet Gajra, Heidi D Klepin, Tao Feng, et al.
Journal of Geriatric Oncology|December 10, 2019
Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancerReena V Jayani, Allison M Magnuson, Can-Lan Sun, et al.
JCO Oncology Practice|July 21, 2025
Oncology Medical Homes: ASCO-Community Oncology Alliance StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Cancer|May 26, 2018
Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancerEnrique Soto-Perez-de-Celis, Can-Lan Sun, William P Tew, et al.
Cancer|November 14, 2023
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trialJingran Ji, Marie Bae, Can-Lan Sun, et al.
Pageof 3